Susquehanna International Group, LLP Summit Therapeutics Inc. Put Options Transaction History

Susquehanna International Group, LLP

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 15, 2024	BUY	$2.39 - $10.92 $274,372 - $1.25 Million	114,800 Added 538.97%	136,100 $1.06 Million
Q1 2024 May 07, 2024	BUY	$2.55 - $5.07 $54,314 - $107,991	21,300 New	21,300 $88,000
Q3 2023 Nov 14, 2023	SELL	$1.54 - $2.42 $1,540 - $2,420	-1,000 Reduced 6.99%	13,300 $24,000
Q2 2023 Aug 11, 2023	SELL	$1.32 - $2.81 $277,332 - $590,381	-210,100 Reduced 93.63%	14,300 $35,000
Q1 2023 May 16, 2023	SELL	$1.38 - $5.41 $631,212 - $2.47 Million	-457,400 Reduced 67.09%	224,400 $392,000
Q4 2022 Feb 14, 2023	BUY	$0.68 - $5.31 $463,624 - $3.62 Million	681,800 New	681,800 $2.9 Million

138

64.4M

1.06M

1.02M

Ticker SMMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,215,008
Market Cap $4.04B
Description
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.